Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COPAGO: Prednisolone versus colchicine for acute gout attacks in primary care
2024-514738-18-00Phase 4Completed
- Sponsor
- Universitätsklinikum Greifswald
- Start
- Sep 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in gout comparing Prednisolone arm with Colchicine arm (2 arms). Primary endpoint: Most severe pain in the last 24 hours. Started Sep 2024; status: completed.
02
Drugs
prednisolonecolchicine
03
Conditions
gout
Beyond the preview
Go deeper on 2024-514738-18-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514738-18-00.